Enzymatic Modulation of the Retinal Barrier Enhances Stem Cell-Derived Neuron Survival

Article Impact Level: HIGH
Data Quality: STRONG
Summary of  Science Translational Medicine https://doi.org/10.1126/scitranslmed.adr1062
Dr. Erika A. Aguzzi et al.

Points

Scientists discovered that a thin tissue layer called the internal limiting membrane acts as a physical barrier that prevents transplanted retinal ganglion cells from integrating into the eye.
Investigators utilized enzymatic solutions to partially digest this membrane in animal models which successfully increased the survival rate of lab-grown human nerve cells to eighty percent.
Research data showed that disrupted membranes allowed up to seven percent of transplanted cells to form dendrites and communicate with other neurons compared to almost zero in control groups.
The study established that these newly integrated cells could extend axons toward the optic nerve and successfully integrate into neural circuits to restore basic responses to light stimulation.
These findings provide a standardized surgical procedure for future clinical trials that could eventually help restore sight to patients suffering from glaucoma or other forms of optic neuropathy.

Summary

This study evaluated the efficacy of disrupting the internal limiting membrane (ILM) to facilitate the engraftment and maturation of transplanted human pluripotent stem cell-derived retinal ganglion cells (hRGCs). Given that RGC degeneration in conditions like glaucoma and optic neuritis results in irreversible vision loss, the research sought to overcome the physical barrier presented by the ILM, which traditionally prevents donor cells from migrating into the retinal neurocircuitry. Investigators utilized multi-species models, including rodents and nonhuman primates, alongside donated human eye tissue to establish whether enzymatic or genetic ILM disruption could restore light responsivity.

Quantitative analysis demonstrated that ILM disruption significantly improved transplantation outcomes. Survival rates reached 95% (45/50) in eyes with inborn membrane defects and 80% (32/40) in enzymatically treated eyes, compared to 75% (12/16) in controls. 3D imaging revealed that maturation and dendrite formation occurred in 7.1% ± 1.6% of hRGCs in mutant eyes and 2.0% ± 0.6% in enzyme-treated eyes. In stark contrast, control eyes exhibited almost negligible migration and maturation rates of 0.01% ± 0.01%. Surviving cells successfully extended axons toward the optic nerve head and integrated into the inner plexiform layer, establishing functional connections.

The findings suggest that the ILM is the primary structural obstacle to successful neuron replacement therapy in the retina. By establishing a surgical and enzymatic protocol for RGC transplantation, this research provides a viable framework for future human clinical trials aimed at reversing optic neuropathy. While functional integration and light responsiveness were observed, the long-term physiological impact of ILM removal remains a subject for ongoing investigation. These results represent a critical advancement in regenerative ophthalmology, moving the field closer to restoring sight in patients with advanced optic nerve damage.

Link to the article: https://www.science.org/doi/10.1126/scitranslmed.adr1062

References

Aguzzi, E. A., Mary, S., Vardanjani, M. M., Godinez, D. R., Kimball, E., Bonakdar, B., Zhang, K. Y., Du, J., Nagalingam, A., Yutzy, W., Quillen, S., Hariharakumar, S., Quigley, H. A., Zack, D. J., Handa, J. T., & Johnson, T. V. (2026). The internal limiting basement membrane inhibits functional engraftment of transplanted human retinal ganglion cells in vivo. Science Translational Medicine, 18(847), eadr1062. https://doi.org/10.1126/scitranslmed.adr1062